Identification of a novel cuproptosis-related gene signature for multiple myeloma diagnosis

被引:3
|
作者
Zhu, Yidong [1 ]
Chang, Shuaikang [2 ]
Liu, Jun [1 ]
Wang, Bo [3 ]
机构
[1] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Tradit Chinese Med, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Dept Hematol, Shanghai East Hosp, Shanghai, Peoples R China
[3] Tongji Univ, Yangpu Hosp, Sch Med, Dept Endocrinol, Shanghai, Peoples R China
关键词
biomarker; cuproptosis; LASSO; multiple myeloma; SVM-RFE; tumor immunity; REGULATORY T-CELLS; HUMAN PYRUVATE-DEHYDROGENASE; MAST-CELLS; STRUCTURAL BASIS; COPPER; PHOSPHORYLATION; DENSITY; DEPOSITION; P14(ARF); COMPLEX;
D O I
10.1002/iid3.1058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundMultiple myeloma (MM) ranks second among the most prevalent hematological malignancies. Recent studies have unearthed the promise of cuproptosis as a novel therapeutic intervention for cancer. However, no research has unveiled the particular roles of cuproptosis-related genes (CRGs) in the prediction of MM diagnosis.MethodsMicroarray data and clinical characteristics of MM patients were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed gene analysis, least absolute shrinkage and selection operator (LASSO) and support vector machine-recursive feature elimination (SVM-RFE) algorithms were applied to identify potential signature genes for MM diagnosis. Predictive performance was further assessed by receiver operating characteristic (ROC) curves, nomogram analysis, and external data sets. Functional enrichment analysis was performed to elucidate the involved mechanisms. Finally, the expression of the identified genes was validated by quantitative real-time polymerase chain reaction (qRT-PCR) in MM cell samples.ResultsThe optimal gene signature was identified using LASSO and SVM-RFE algorithms based on the differentially expressed CRGs: ATP7A, FDX1, PDHA1, PDHB, MTF1, CDKN2A, and DLST. Our gene signature-based nomogram revealed a high degree of accuracy in predicting MM diagnosis. ROC curves showed the signature had dependable predictive ability across all data sets, with area under the curve values exceeding 0.80. Additionally, functional enrichment analysis suggested significant associations between the signature genes and immune-related pathways. The expression of the genes was validated in MM cells, indicating the robustness of these findings.ConclusionWe discovered and validated a novel CRG signature with strong predictive capability for diagnosing MM, potentially implicated in MM pathogenesis and progression through immune-related pathways. We identified a novel signature associated with cuproptosis-related genes, which exhibited a strong diagnostic value for multiple myeloma (MM). Our study highlights the involvement of cuproptosis-related genes in the diagnosis of MM and investigates the underlying molecular mechanisms, offering novel insights into the pathogenesis and progression of MM.image
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
    Chen, Yuqiao
    Tang, Lu
    Huang, Wentao
    Abisola, Fakolade Hannah
    Zhang, Youyu
    Zhang, Gewen
    Yao, Lei
    BIOLOGY DIRECT, 2023, 18 (01)
  • [22] Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
    Liu, Binfeng
    Liu, Zhongyue
    Feng, Chengyao
    Li, Chenbei
    Zhang, Haixia
    Li, Zhihong
    Tu, Chao
    He, Shasha
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [23] Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma
    Chen, Yuqiao
    Tang, Lu
    Huang, Wentao
    Zhang, Youyu
    Abisola, Fakolade Hannah
    Li, Linfeng
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [24] Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction
    Liu, Zheng
    Wang, Lei
    Xing, Qichang
    Liu, Xiang
    Hu, Yixiang
    Li, Wencan
    Yan, Qingzi
    Liu, Renzhu
    Huang, Nan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [25] Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas
    Bao, Jia-hao
    Lu, Wei-cheng
    Duan, Hao
    Ye, Ya-qi
    Li, Jiang-bo
    Liao, Wen-ting
    Li, Yong-chun
    Sun, Yang-peng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [26] A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
    Luo, Bixian
    Lin, Jianwei
    Ni, Anqi
    Cai, Wei
    Yu, Xinbo
    Wang, Mingliang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Novel cuproptosis-related lncRNAs can predict the prognosis of patients with multiple myeloma
    Chen, Yuying
    Tang, Jialin
    Chen, Lin
    Chen, Jianbin
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (11) : 3074 - 3087
  • [28] A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis
    Yuting Cui
    Yanyu Chen
    Ni Gan
    Man Li
    Wei Liao
    Yating Zhou
    Qiong Xiang
    Xi Gong
    Qianqian Guo
    Pengwei Hu
    Xi-Long Zheng
    Desi Shang
    Juan Peng
    Zhihan Tang
    Molecular Biomedicine, 4
  • [29] A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma
    Zhang, Huizhe
    Shi, Yanchen
    Yi, Qing
    Wang, Cong
    Xia, Qingqing
    Zhang, Yufeng
    Jiang, Weilong
    Qi, Jia
    FRONTIERS IN GENETICS, 2022, 13
  • [30] A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis
    Cui, Yuting
    Chen, Yanyu
    Gan, Ni
    Li, Man
    Liao, Wei
    Zhou, Yating
    Xiang, Qiong
    Gong, Xi
    Guo, Qianqian
    Hu, Pengwei
    Zheng, Xi-Long
    Shang, Desi
    Peng, Juan
    Tang, Zhihan
    MOLECULAR BIOMEDICINE, 2023, 4 (01):